DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Eriksson BI, Dahl OE, Rosencher N , et al; RE-NOVATE Study Group.
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.
Lancet 2007;
370 (9591) 949-956
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.